Digitek Wrongful Death Lawsuits

Austin Kirk

By Austin Kirk
Posted December 30, 2008

ADD YOUR COMMENTS 2

The attorneys at Saiontz & Kirk have been investigating potential Digitek lawsuits since the generic heart drug was recalled in April 2008. Although Actavis has attempted to argue that none of the oversized tablets ever reached the public, according to reports of adverse events submitted to the FDA, there have been at least 667 Digitek deaths reported where the drug was identified as the “primary suspect.”

On April 25, 2008, Actavis recalled all lots of their generic digoxin heart drug after it was found that some of the tablets were twice as thick as they were supposed to be, containing excess of digoxin. This poses a serious risk to users of the drug, as a digoxin overdose could lead to digitalis toxicity, with symptoms like nausea, low blood pressure, cardiac instability, bradycardia (slow heartbeat) or even death.

On December 24, 2008, eight months after the Digitek recall, a report was published by the Center for Public Integrity indicating that there was a spike in adverse event reports involving the drug earlier this year and that there have been over 650 Digitek deaths reported between April 1, 2008 and June 30, 2008.

This data seriously calls into question the assertions by Actavis that they caught all of the oversized Digitek tablets before they were distributed to the public.

The report also criticized the steps taken after the recall to notify consumers, healthcare providers and pharmacists about the recall and the risk of potentially fatal injury associated with continued use of Digitek.

DIGITEK RECALL ATTORNEYS

The Digitek attorneys at Saiontz & Kirk are investigating a number of potential wrongful death lawsuits and other claims for injuries associated with the use of Digitek. Lawsuits are being evaluated on behalf of individuals throughout the United States and there are no fees or expenses unless a recovery is obtained.

Many users of the heart drug and family members continue to remain unaware of the Digitek recall or that serious injury or death suffered while taking the drug may be related to oversized tablets. To have a potential lawsuit evaluated and reviewed by our Digitek attorneys, request a free consultation.

2 Comments • Add Your Comments

  • Patricia says:

    My mother had taken Digitek from 5/24/07-3/20/08 and I feel it contributed to her death 9/3/08–whcih was from the stent in her
    aorta failed to function and an aneurysm on the aorta burst, killing
    her. She had heart disease, a defective valve, angina and congestive heart failure

    Posted on January 15, 2009 at 4:06 pm

  • Patti says:

    My husband, Jimmy, received the double thickness digitek tablets in May of 2008, and took them for just over a week when we were notified of the error in manufacturing. The company wanted us to return the unused portion but I kept them. My husband had congestive heart failure, with ventricular tachycardia, and had a pacemaker/defibrillator. He was doing very well with the medications he was taking until receiving the overdose. After receiving it he started having multiple episodes of v-tach, causing his defibrillator to fire eight (8) times in a six week period, he had to have two stents placed due to the excess damage caused, and slowly went downhill in health until his recent death on April 2nd, 2009. All of this was caused by the digitek overdose! He had been completely stabilized with his medications prior to the overdose, but was never able to fully regain his strength after it. They need to be held responsible for their ‘mistake’! I’ve lost my husband, and best friend because of them!

    Posted on April 15, 2009 at 3:15 pm

Add Your Comments

  • This field is for validation purposes and should be left unchanged.
  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.